Detection of pyrogenic toxins of Staphylococcus aureus in sudden infant death syndrome

A Zorgani1, S D Essery, O A Madani

  • 1Department of Medical Microbiology, The Medical School, University of Edinburgh, UK.

Insights

Pyrogenic toxins from Staphylococcus aureus were found in over 50% of sudden infant death syndrome (SIDS) cases across three countries. This suggests a potential role for these toxins in infant deaths, warranting further investigation for prevention strategies.

Area of Science:

  • Microbiology
  • Toxicology
  • Pediatrics

Background:

  • Sudden Infant Death Syndrome (SIDS) is a leading cause of post-neonatal mortality.
  • Staphylococcus aureus pyrogenic toxins are hypothesized to contribute to SIDS pathogenesis.

Purpose of the Study:

  • To screen SIDS infant tissues for Staphylococcus aureus pyrogenic toxins.
  • To compare the incidence of these toxins in SIDS infants internationally.
  • To evaluate detection methods for these toxins in various tissue types.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) and flow cytometry were employed.
  • Screening included body fluids and frozen or formalin-fixed tissues.
  • Specific toxins targeted: toxic shock syndrome toxin 1 (TSST), staphylococcal enterotoxins A (SEA), B (SEB), and C1 (SEC).

Main Results:

  • Pyrogenic toxins were identified in 33/62 (53%) of SIDS infants from Scotland, France, and Australia.
  • A significantly lower incidence (16%) was observed in non-SIDS deaths in Australia (chi2 = 5.42, P < 0.02).
  • Flow cytometry proved effective for both frozen and fixed tissues; ELISA was limited to fresh or <12-month fixed tissues.

Conclusions:

  • The high prevalence of pyrogenic toxins in SIDS cases across multiple countries supports further research.
  • Investigating the role of these toxins in cot deaths may lead to new preventative measures.
  • Improved diagnostic methods, like flow cytometry, enhance toxin detection in diverse SIDS-related tissues.

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...